British Journal of Dermatology

<jats:title>Abstract</jats:title>
               <jats:sec>
                  <jats:title>Background</jats:title>
                  <jats:p>Sunscreen reduces vitamin D production in experimental studies. It is uncertain whether this translates to real-world settings.</jats:p>
               </jats:sec>
               <jats:sec>
                  <jats:title>Objectives</jats:title>
                  <jats:p>To determine if routinely applying high sun protection factor (SPF) sunscreen for a year reduces serum 25-hydroxyvitamin D [25(OH)D] concentration.</jats:p>
               </jats:sec>
               <jats:sec>
                  <jats:title>Methods</jats:title>
                  <jats:p>We conducted a population-based open-label randomized controlled trial in Australian participants aged 18–70 years who were not routinely using sunscreen or taking vitamin D supplements. Participants were randomized (1 : 1) using stratified, computer-generated permuted block randomization to routine application of SPF 50+ sunscreen on days the ultraviolet (UV) index was forecast to reach ≥ 3 (intervention) or discretionary sunscreen use (control), for approximately 1 year. We measured 25(OH)D concentration at baseline (winter/spring 2022) and at the end of summer and winter 2023; participants with no postbaseline concentrations (n = 11) were excluded from analyses. The primary outcome was change in 25(OH)D concentration from baseline. Vitamin D deficiency [25(OH)D concentration &amp;lt; 50 nmol L–1] in the final sample was an exploratory outcome. We analysed data using mixed-effects models and Poisson regression. We stratified our analysis by baseline 25(OH)D concentration, residential UV radiation (UVR) zone, skin exposure (derived from time outdoors and clothing use) and personal UVR exposure (derived by combining UVR zone and skin exposure). Sample and data analysis were performed blind to randomization group. The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12621001752853).</jats:p>
               </jats:sec>
               <jats:sec>
                  <jats:title>Results</jats:title>
                  <jats:p>Between 30 June and 29 November 2022, we randomized 639 participants (intervention, n = 319; control, n = 320). In total, 628 participants were analysed [intervention, n = 312; control, n = 316; median age 52 years (interquartile range 40–64)]. Altogether, 415 (66.1%) identified as female, 210 (33.4%) as male and 3 (0.5%) used another term. Mean (SD) baseline 25(OH)D concentration was balanced [intervention 63.5 (21.9) nmol L–1; control 62.1 (22.8) nmol L–1]. Adjusted mean differences from baseline were 1.6 nmol L–1 (intervention) and 6.8 nmol L–1 (control) [between-group treatment effect –5.2 nmol L–1, 95% confidence interval (CI) –7.2 to –3.2]. Treatment effects were consistent across almost all subgroups. Vitamin D deficiency (final sample) was higher in the intervention (n = 139/304; 45.7%) than in the control group (n = 115/312; 36.9%) (prevalence ratio 1.33, 95% CI 1.14–1.55).</jats:p>
               </jats:sec>
               <jats:sec>
                  <jats:title>Conclusions</jats:title>
                  <jats:p>Routinely applying high SPF sunscreen results in lower 25(OH)D concentrations than would be seen with discretionary sunscreen use. Regular sunscreen users may need vitamin D supplementation.</jats:p>
               </jats:sec>

National Health and Medical Research Council

the University of Queensland

Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012

Int J Cancer

Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use

Aust N Z J Public Health

Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial

Lancet

Reduced melanoma after regular sunscreen use: randomized trial follow-up

J Clin Oncol

Reduction of solar keratoses by regular sunscreen use

N Engl J Med

When to apply sunscreen: a consensus statement for Australia and New Zealand

Health effects of vitamin D supplementation: lessons learned from randomized controlled trials and Mendelian randomization studies

J Bone Miner Res

Vitamin D ­deficiency in Europe: pandemic?

Am J Clin Nutr

National estimates of serum total 25-hydroxyvitamin D and metabolite concentrations measured by liquid chromatography–tandem mass spectrometry in the US population during 2007–2010

J Nutr

The effect of sunscreen on vitamin D: a review

Br J Dermatol

Sun protection and vitamin D status in an Australian subtropical community

Prev Med

The effect of regular sunscreen use on vitamin D levels in an Australian population: results of a randomized controlled trial

Arch Dermatol

Balancing the risks and benefits of sun exposure: a revised position statement for Australian adults

About

SunSmart App

Optimized 25-hydroxyvitamin D analysis using liquid–liquid extraction with 2D separation with LC/MS/MS detection, provides superior precision compared to conventional assays

Metabolomics

Optimal sunscreen use, during a sun holiday with a very high ultraviolet index, allows vitamin D synthesis without sunburn

Physical determinants of vitamin D photosynthesis: a review

JBMR Plus

Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline

J Clin Endocrinol Metab

Evidence of low vitamin D intakes in the Australian population points to a need for data-driven nutrition policy for improving population vitamin D status

J Hum Nutr Diet

Sunscreen reduces vitamin D production in experimental studies. It is uncertain whether this translates to 'real-world' settings.
We aimed to dtermine if routinely applying high-SPF sunscreen for one year reduces serum 25-hydroxyvitamin D [25(OH)D] concentration.
We conducted a population-based, open-label, randomised, controlled trial in Australians aged 18-70 years, who were not routinely using sunscreen/vitamin D. Participants were randomised (1:1) using stratified, computer-generated permuted block randomisation to routine application of SPF 50+ sunscreen on days the UV Index was forecast to reach ≥3 (intervention), or discretionary sunscreen use (control), for ∼1 year. We measured 25(OH)D concentration at baseline (winter/spring 2022), and at end of summer and winter 2023; we excluded from analyses participants with no post-baseline concentrations (n=11). The primary outcome was change in 25(OH)D concentration from baseline. Vitamin D deficiency (25(OH)D concentration <50 nmol/L) in the final sample was an exploratory outcome. We analysed data using mixed-effects models and Poisson regression. We stratified our analysis by baseline 25(OH)D concentration, residential UV radiation zone, skin exposure (derived from time outdoors and clothing use), and personal UV radiation exposure (derived by combining UV radiation zone and skin exposure). Sample and data analysis were performed blind to randomisation group. Trial registration: Australian New Zealand Clinical Trials Registry (ACTRN12621001752853).
Between June 30, 2022, and November 29, 2022, we randomised 639 participants (intervention, n=319; control, n=320). 628 participants were analysed (intervention, n=312; control, n=316; median age, 52 years (IQR 40-64)). 415 (66%) identified as female, 210 (33%) as male, 3 (0.5%) used another term. Baseline 25(OH)D concentration was balanced (mean (SD): intervention, 63.5 (21.9) nmol/L; control, 62.1 (22.8) nmol/L). Adjusted mean differences from baseline were 1.6 nmol/L (intervention) and 6.8 nmol/L (control) (between-group treatment effect, -5.2 nmol/L; 95% CI, -7.2, -3.2). The treatment effects were consistent across almost all subgroups. Vitamin D deficiency (final sample) was higher in the intervention (n=139 [46%]) compared with the control group (n=115 [37%]) (prevalence ratio, 1.33, 95% CI, 1.14, 1.55).
Routinely applying high-SPF sunscreen results in lower 25(OH)D concentrations than would be observed with discretionary sunscreen use. Regular sunscreen users may need supplementary vitamin D.

The effect of daily sunscreen application on vitamin D: findings from the open-label, randomised, controlled Sun-D Trial.

The effect of daily sunscreen application on vitamin D: findings from the open-label, randomised, controlled Sun-D Trial

Effect of daily sunscreen application on vitamin D: findings from the open-label randomized controlled Sun-D Trial

Effect of daily sunscreen application on vitamin D: findings from the open-label randomized controlled Sun-D Trial

Clinical Summary

What was studied

Key findings

Study limitations

Clinical implications

Related Questions